Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Plexpress' TRACPack Dog Induction Screening Service


Plexpress has launched an ADME-Tox screening service for canine preclinical drug candidate screening.

Called TRACPack Dog Induction, Plexpress' service is based on its transcript analysis with the aid of affinity capture, or TRAC, method of gene expression analysis.

The Helsinki, Finland-based firm said in a statement that the screening service provides canine cytochrome P450 mRNA analysis using primary dog hepatocytes followed by CYP enzyme activity measurements. Hepatocytes from three separate donors are used, the firm said, generating CYP mRNA expression and protein activity data produced in line with US Food and Drug Administration recommendations for human hepatocytes.

It added that its new panel includes "all relevant CYP targets and reference genes, ready-to-analyze in a single well for high-throughput multiplexing." Additional genes can also be included according to study needs, Plexpress said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.